180 Wealth Advisors, LLC

SEC CIK: 0001730817
Latest filing: Jul 7, 2026

SEC filings (opens in a new tab)

EPRX holding history

Eupraxia Pharmaceuticals Inc. in every 13F filed by 180 Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EPRX overview All 13F holders of EPRX Full Q2 2026 holdings

Shares (Q1 2025): 0; Sold out in Q1 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2024

Holdings of EPRX by 180 Wealth Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2025	0	$0	0.0%	−10,500−100.0%	Sold out	Holders
Q4 2024	10,500	$33.3K	<0.1%	−2,500−19.2%	Reduced	Holders
Q3 2024	13,000	$34.2K	<0.1%	00.0%	Unchanged	Holders
Q2 2024	13,000	$34.1K	<0.1%	+13,000	New	Holders